Last reviewed · How we verify
Echinaforce Chewable tablets
Echinaforce contains Echinacea purpurea extract that stimulates immune function to help the body fight infections and reduce cold/flu symptoms.
Echinaforce contains Echinacea purpurea extract that stimulates immune function to help the body fight infections and reduce cold/flu symptoms. Used for Prevention and treatment of common cold and influenza-like infections, Reduction of duration and severity of upper respiratory tract infection symptoms.
At a glance
| Generic name | Echinaforce Chewable tablets |
|---|---|
| Also known as | Echinacea, Echinaforce, Echinaforce Junior tablets |
| Sponsor | A. Vogel AG |
| Drug class | Herbal immune stimulant |
| Modality | Small molecule |
| Therapeutic area | Immunology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Echinacea purpurea is believed to enhance innate immune responses by activating macrophages, natural killer cells, and other immune components. The herb contains polysaccharides, alkamides, and phenolic compounds that may promote cytokine production and improve immune cell activity, potentially reducing the severity and duration of upper respiratory tract infections.
Approved indications
- Prevention and treatment of common cold and influenza-like infections
- Reduction of duration and severity of upper respiratory tract infection symptoms
Common side effects
- Gastrointestinal upset
- Allergic reactions (rare, in individuals with ragweed sensitivity)
- Dizziness
Key clinical trials
- Echinaforce COVID-19 Shedding Study (PHASE4)
- Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |